Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$127.59 - $203.08 $118,148 - $188,052
926 New
926 $187,000
Q2 2022

Aug 15, 2022

SELL
$108.81 - $179.33 $2,720 - $4,483
-25 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$119.61 - $157.85 $2,990 - $3,946
25 New
25 $4,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.